InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（39 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
39
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Boulding Mark Elliott, Vice-Président Exécutif et Directeur Juridique. Director active across 1 company, notably PTC Therapeutics, INC.. Cumulatively, 70 disclosures have been recorded. Split: 0 buy · 39 sells. Total volume traded: €2.7m. Activity tracked since 8 July 2021. The latest transaction was disclosed on 17 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Boulding Mark Elliott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报70 总计
2,813 股@ US$25.69Common StockSEC:0001578852-26-000022:0
1,844 股@ US$72.39Common StockSEC:0001578852-26-000022:1
969 股@ US$72.90Common StockSEC:0001578852-26-000022:2
601 股@ US$86.380.0007% mcap0.8% 占其流量Common StockSEC:0001578852-26-000020:4
2,266 股@ US$39.420.0012% mcap1.4% 占其流量Common StockSEC:0001578852-26-000020:0
313 股@ US$83.100.0004% mcap0.4% 占其流量Common StockSEC:0001578852-26-000020:1
833 股@ US$84.410.0009% mcap1.1% 占其流量Common StockSEC:0001578852-26-000020:2
519 股@ US$85.840.0006% mcap0.7% 占其流量Common StockSEC:0001578852-26-000020:3
2,813 股@ US$46.540.0018% mcap2.0% 占其流量Common StockSEC:0001578852-26-000020:5
387 股@ US$83.100.0004% mcap0.5% 占其流量Common StockSEC:0001578852-26-000020:6
1,036 股@ US$84.410.0012% mcap1.4% 占其流量Common StockSEC:0001578852-26-000020:7
645 股@ US$85.840.0007% mcap0.9% 占其流量Common StockSEC:0001578852-26-000020:8
745 股@ US$86.380.0009% mcap1.0% 占其流量Common StockSEC:0001578852-26-000020:9
2,012 股Common StockSEC:0001578852-26-000018:3
309 股Common StockSEC:0001578852-26-000018:5
8,510 股Common StockSEC:0001578852-26-000018:0
6,600 股Common StockSEC:0001578852-26-000018:1
1,850 股Common StockSEC:0001578852-26-000018:2
1,703 股Common StockSEC:0001578852-26-000018:4
2,265 股@ US$39.421.5% 占其流量Common StockSEC:0001578852-26-000012:0
822 股@ US$68.911.0% 占其流量Common StockSEC:0001578852-26-000012:1
1,443 股@ US$69.751.7% 占其流量Common StockSEC:0001578852-26-000012:2
588 股@ US$68.540.5% 占其流量Common StockSEC:0001578852-26-000010:0
2,813 股@ US$25.690.9% 占其流量Common StockSEC:0001578852-26-000008:0
2,482 股@ US$76.562.3% 占其流量Common StockSEC:0001578852-26-000006:0
70 条申报中的 25 条
About Boulding Mark Elliott
Boulding Mark Elliott is Executive Vice President and Chief Legal Officer. He has 67 filings in total, all included in the recent sample, and the transactions recorded over the period from 2021-07-12 to 2026-07-08 show sell volume of EUR 2560556, with the dominant transaction nature stated as Disposition. The largest recent filings concern PTC Therapeutics, INC., including EUR 1380075.46731931 on 2025-03-12, EUR 609331.302997165 on 2025-10-07, and EUR 579158.4161537292 on 2025-09-15.
